1. J Bone Miner Res 2013; 28:2266 (Fig. 2)
Reproduced from J Bone Miner Res 2013; 28: with permission of the American Society of Bone and Mineral Research.

2. J Bone Miner Res 2013; 28:2266 (Fig. 3)
Reproduced from J Bone Miner Res 2013; 28: with permission of the American Society of Bone and Mineral Research.

3. Whitmarsh T, Treece G, Gee A, Poole K 2013 Cortical thickness and density changes over the proximal femur resulting from switching to or combining with teriparatide after prior treatment with raloxifene or alendronate. J Bone Miner Res 28 (Suppl 1). Available at Accessed November 25, 2013.
Reproduced with permission of the American Society of Bone and Mineral Research.

4. Genant HK, Boonen S, Bolognese MA, Mautalen C, Brown JP, Recknor C, Goemaere S, Engelke K, Yang YC, Austin M, Grauer A, Libanati C 2013 Effect of romosozumab on lumbar spine and hip volumetric bone mineral density (vBMD) as assessed by quantitative computed tomography (QCT). J Bone Miner Res 28 (Suppl 1). Available at Accessed November 25, 2013.
Reproduced with permission of the American Society of Bone and Mineral Research.

5. Li X, Warmington KS, Niu QT, Dwyer D, Han CY, Stolina M, Grauer A, Ke HZ 2013 Retreatment with sclerostin antibody increased bone formation and bone mass in ovariectomized rats. J Bone Miner Res 28 (Suppl 1). Available at Accessed November 25, 2013.
Reproduced with permission of the American Society of Bone and Mineral Research.